Cardioprotective Effects of Sphingosine-1-Phosphate Receptor Immunomodulator FTY720 in a Clinically Relevant Model of Cardioplegic Arrest and Cardiopulmonary Bypass.

Front Pharmacol · 2019 · PMC6656862 · PMID 31379576

Europe PMC DOI

hedged sentence

0.2000

closest p · 4.0× alpha

0.2000

boldest claim

The sentences

did not reach statistical significancep = 0.2not close (p > 0.1)

Ventricular systolic performance dP/dt max after CPB was improved in the FTY720-treated versus control group but did not reach statistical significance ( p = 0.2).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.